retatrutide clinical trial fat loss A new weight-loss drug called is generating excitement after participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Retatrutide trial, 57 days into
Description
Known for its active ingredient, tirzepatide, Zepbound is specifically FDA-approved for weight management

Understanding this mechanism clarifies why GLP-1-based therapies have become central to modern diabetes and obesity management

Pt A, Dec

Epub 2022 Jun 4

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Zhu L., et al

Perimenopause Weight Loss: A Guide to HRT and GLP-1 Medications Weight gain during perimenopause affects many women in their 40s and early 50s, with research showing an average gain of 1.1 pounds per year due to aging during this period of life
